Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation

被引：2
|
作者：
Castagna, L. [1 ]
Sarina, B. [1 ,8 ]
Crocchiolo, R. [1 ,4 ]
Bramanti, S. [4 ,5 ,7 ]
Furst, S. [3 ,4 ,6 ,8 ]
Devillier, R. [2 ,4 ,5 ,7 ]
Coso, D. [2 ,9 ]
Bouabdallah, R. [3 ,5 ]
Mokart, D. [6 ,8 ]
Morabito, L. [6 ]
Harbi, S. [2 ,8 ,9 ]
Giordano, L. [7 ]
Rimondo, A.
Weiller, P. Jean
Carlo-Stella, C. [9 ]
Santoro, A. [3 ]
Chabannon, C.
Blaise, D.
机构：
[1] Dept Hematol, Transplantat Program, Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Rozzano, Italy
[2] Dept Hematol, Lymphoma Program, Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Rozzano, Italy
[3] Inst Paoli Calmettes, Intens Care Unit, Marseille, France
[4] Biostatist Unit, Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Rozzano, Italy
[5] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy
[6] Humanitas Univ, Rozzano, Italy
[7] Inst Paoli Calmettes, Cell Therapy Unit, Marseille, France
[8] Aix Marseille Univ, Marseille, France
[9] Aix Marseille Univ, Inst Paoli Calmettes, Ctr Rech Cancerol Marseille, INSERM, Marseille, France
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷 / 12期
关键词：
BRENTUXIMAB VEDOTIN;
D O I：
10.1038/bmt.2016.257
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1644 / 1646
页数：3
相关论文
共 50 条
  • [1] Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation
    L Castagna
    B Sarina
    R Crocchiolo
    S Bramanti
    S Furst
    R Devillier
    D Coso
    R Bouabdallah
    D Mokart
    L Morabito
    S Harbi
    L Giordano
    A Rimondo
    P Jean Weiller
    C Carlo-Stella
    A Santoro
    C Chabannon
    D Blaise
    Bone Marrow Transplantation, 2016, 51 : 1644 - 1646
  • [2] Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation
    Kim, Ji-Won
    Kim, Byung-Su
    Bang, Soo-Mee
    Kim, Inho
    Kim, Dong Hwan
    Kim, Won Seog
    Yang, Deok-Hwan
    Lee, Je-Jung
    Lee, Je-Hwan
    Kim, Jin Seok
    Sohn, Sang-Kyun
    Yhim, Ho-Young
    Kwak, Jae-Yong
    Yoon, Sung-Soo
    Lee, Jong Seok
    Park, Seonyang
    Kim, Byoung Kook
    ANNALS OF HEMATOLOGY, 2011, 90 (12) : 1409 - 1418
  • [3] Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation
    Ji-Won Kim
    Byung-Su Kim
    Soo-Mee Bang
    Inho Kim
    Dong Hwan Kim
    Won Seog Kim
    Deok-Hwan Yang
    Je-Jung Lee
    Je-Hwan Lee
    Jin Seok Kim
    Sang-Kyun Sohn
    Ho-Young Yhim
    Jae-Yong Kwak
    Sung-Soo Yoon
    Jong Seok Lee
    Seonyang Park
    Byoung Kook Kim
    Annals of Hematology, 2011, 90 : 1409 - 1418
  • [4] Risk of second cancer in patients with Hodgkin Lymphoma who relapse after autologous stem cell transplantation
    Gotti, M.
    Colombo, A. A.
    Bernasconi, P.
    Caldera, D.
    Barate, C.
    Ripamonti, F.
    Pascutto, C.
    Lazzarino, M.
    Brusamolino, E.
    Alessandrino, E. P.
    ANNALS OF ONCOLOGY, 2008, 19 : 244 - 245
  • [5] Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation
    Porter, DL
    Luger, SM
    Duffy, KM
    Stadtmauer, EA
    Laport, G
    Schuster, SJ
    Orloff, G
    Tsai, D
    McDaid, K
    Kathakali, A
    Leonard, DGB
    Antin, JH
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (04) : 230 - 238
  • [6] Risk factors and outcomes for relapse after autologous stem cell transplantation for Hodgkin lymphoma.
    Dean, Robert M.
    Sweetenham, John. W.
    Jin, Tao
    Brown, Stacey
    Pohlman, Brad
    Sobecks, Ronald
    Kalaycio, Matt
    Andresen, Steve
    Copelan, Edward A.
    Bolwell, Brian J.
    BLOOD, 2007, 110 (11) : 565A - 565A
  • [7] Outcomes for Patients with Classical Hodgkin Lymphoma Who Relapse after Autologous Stem Cell Transplant in the Era of Novel Therapies
    Stuver, Robert
    Drill, Esther
    Ganesan, Nivetha
    Baron, Kelsey
    Casper, Ellie
    Chang, Tiffany
    Desai, Sanjal H.
    Falade, Ayo S.
    Galasso, Natasha
    Herrera, Alex F.
    Mei, Matthew G.
    Merryman, Reid W.
    Micallef, Ivana
    Shah, Harsh
    Moskowitz, Alison
    BLOOD, 2023, 142
  • [8] Gemcitabine-Based Salvage Chemotherapy as a Bridge to Allogeneic Hematopoietic Stem Cell Transplantation for the Patients with Relapse of Hodgkin Lymphoma After Autologous Hematopoietic Stem Cell Transplantation
    Czyz, Anna
    Nowicki, Adam
    Gil, Lidia
    Dytfeld, Dominik
    Lojko-Dankowska, Anna
    Styczynski, Jan
    Komarnicki, Mieczyslaw
    BLOOD, 2010, 116 (21) : 1164 - 1164
  • [9] Allogeneic stem cell transplantation in patients with Hodgkin's-Lymphoma
    Pohl, H
    Shimoni, A
    Kroeger, N
    Martin, H
    Vucinic, V
    Basara, N
    Nagler, A
    Zander, A
    Fauser, AA
    Kiehl, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 605S - 605S
  • [10] Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma
    Reddy, Nishitha M.
    Oluwole, Olalekan
    Greer, John P.
    Engelhardt, Brian G.
    Jagasia, Madan H.
    Savani, Bipin N.
    EXPERIMENTAL HEMATOLOGY, 2014, 42 (01) : 39 - 45
12345